Login
Résultat de la recherche (1-20 par 106)Download
|
Symbol
|
RMAFFV | RMAHIV | OTSRCH | OVLRCH | AAYMTQ | RMA9EV | RMBPAV | RMASDV | RMBQSV | ABKBTQ | PHKRCH | RMADDV | RMAH4V | RMBHZV | PMXRCH | RMA3WV | RMBSMV | PSNRCH | MBSXJB | PTDRCH |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nom | Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Worst of Reverse Convertible | Worst of Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Worst of Reverse Convertible | Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Worst of Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Worst of Reverse Convertible | Callable Multi Barrier Reverse Convertible | Barrier Reverse Convertible |
|
Sous-jacent
|
Alcon / Galderma Group AG / Sandoz Group AG | Estée Lauder Co. Inc. / Galderma Group AG / L'Oréal S.A. / UNILEVER TMICC BASKET | Bachem Hldg. AG / Galderma Group AG / Sandoz Group AG | Galderma Group AG / Roche AG / Straumann Hldg. AG | Bachem Hldg. AG / Galderma Group AG / Straumann Hldg. AG | Douglas Hldg. AG / Galderma Group AG / UNILEVER TMICC BASKET | CREDIT SUISSE UBS MERGER / Galderma Group AG / Sonova Hldg. AG | Galderma Group AG / Givaudan / Ypsomed Hldg. AG | CREDIT SUISSE UBS MERGER / DOCMORRIS AG / Galderma Group AG | Alcon / Galderma Group AG / Novartis AG / Sandoz Group AG | Galderma Group AG / Sandoz Group AG / Sanofi S.A. | Galderma Group AG / Lonza Group N / Novartis AG / Roche AG / Sandoz Group AG | Galderma Group AG / Givaudan / Straumann Hldg. AG | DOCMORRIS AG / Galderma Group AG / Sandoz Group AG | Galderma Group AG / Kühne & Nagel Intl. AG / Partners Group Hldg. AG / SIG Combibloc | Compagnie Financière Richemont SA / Galderma Group AG / Givaudan | Galderma Group AG / ON Holding AG. / Straumann Hldg. AG | Galderma Group AG / Lonza Group N / Novartis AG | Galderma Group AG / Givaudan / Sandoz Group AG / Straumann Hldg. AG | Galderma Group AG / Sandoz Group AG |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
29.06.2026 | 24.02.2026 | 02.03.2026 | 13.03.2026 | 20.03.2026 | 28.09.2026 | 27.04.2026 | 11.05.2026 | 18.05.2026 | 12.11.2026 | 02.09.2026 | 05.01.2027 | 10.07.2026 | 17.07.2026 | 24.07.2026 | 17.07.2026 | 07.08.2026 | 03.12.2026 | 11.03.2026 | 03.06.2026 |
| Demande | 90,50 | - | 86,69 | 99,05 | 80,23 | 58,90 | 56,40 | 82,70 | 36,300 | - | 86,00 | 99,40 | 90,50 | 64,30 | 65,69 | 94,50 | 84,70 | - | - | 100,70 |
| Offre | 91,80 | - | 92,50 | - | - | - | 58,00 | - | - | - | - | 100,20 | - | - | - | 95,30 | 85,50 | - | - | - |
S'il vous plait attendre
Le push de données de prix a été désactivé en raison d'un timeout. S'il vous plaît cliquez sur "Actualiser la page" pour continuer.
Votre mémo (0)